This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Oncology

Australia orders Elekta
Australia orders Elekta
Collaboration using IT in brachytherapy
Collaboration using IT in brachytherapy
Chemotherapy drug damages brain, say researchers
Chemotherapy drug damages brain, say researchers
Denied cancer patient wins appeal
Denied cancer patient wins appeal
Cancer treatment gets approval
Cancer treatment gets approval
Uppsala University Hospital evaluates diagnostics platform
Uppsala University Hospital evaluates diagnostics platform
CytoCore launches smear testing product in Spain
CytoCore launches smear testing product in Spain
Scottish Government opens consultation on cancer care
Scottish Government opens consultation on cancer care
Salmond hails new cancer centre
Salmond hails new cancer centre
New treatment for benign breast tumour
New treatment for benign breast tumour
Thalidomide-based treatment for myeloma could be approved in Europe
Thalidomide-based treatment for myeloma could be approved in Europe
Patients “died after biopsy error”
Patients “died after biopsy error”


Popular articles

RCT finds bempedoic acid reduces cardiovascular adverse events for statin-intolerant patients
Pholcodine containing cough and cold medicines withdrawn from UK market
Artificial sweetener erythritol use in cardiac patients associated with increased MACE risk
Ketogenic diet linked to higher LDL cholesterol and increased risk of adverse cardiac events
Oral PCSK9 inhibitor significantly lowers LDL cholesterol in adults with hypercholesterolaemia




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora